RevCycle Intelligence November 27, 2023
The growth of Medicare Part D claims subject to 340B discounts was driven by increases in claims written by 340B-affiliated clinicians and prescribed by 340B pharmacies.
The share of Medicare Part D claims eligible for discounts in the 340B drug pricing program increased from 1.7 percent to 9.6 percent between 2013 and 2020, a study published in JAMA Health Forum indicated.
The 340B program allows certain healthcare entities to acquire outpatient prescription drugs at a discounted price. These entities often include disproportionate share hospitals, children’s hospitals, free-standing cancer hospitals, critical access hospitals, and federally qualified health centers.
Prescriptions must be written by a 340B-affiliated clinician and dispensed from an in-house or contract pharmacy to be eligible for 340B discounts.
Researchers...